Description of Business and Basis of Presentation (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2026 |
Feb. 28, 2026 |
Jan. 30, 2026 |
Dec. 31, 2025 |
|
| Organization Consolidation And Presentation Of Financial Statements [Line Items] | ||||
| Cash and cash equivalents | $ 98,086 | $ 88,932 | ||
| Accumulated deficit | $ 302,558 | $ 326,692 | ||
| vTv Therapeutics LLC | ||||
| Organization Consolidation And Presentation Of Financial Statements [Line Items] | ||||
| Percentage of non-voting economic interest of vTv Therapeutics Inc in vTv LLC | 100.00% | |||
| Newsoara Biopharma Co Ltd | Collaborative Arrangements | ||||
| Organization Consolidation And Presentation Of Financial Statements [Line Items] | ||||
| License fee received | $ 20,000 | $ 20,000 | ||
| Parent Company | ||||
| Organization Consolidation And Presentation Of Financial Statements [Line Items] | ||||
| Cash and cash equivalents | $ 78,000 |